About the Journal

About Ricos Biology Journal

Ricos Biology Journal is a multidisciplinary, open-access journal dedicated to publishing high-quality, original research across the full spectrum of biological, medical, biomedical, and pharmaceutical sciences. Published by Ricos Publisher, a division of the UK-based Xeno Group Ltd. Ricos Biology Journal is directed the Editor  on-chief, Prof. Abouelhag H.A., Professor of Microbiology and Immunology, Microbiology and Immunology Dept., National Research Centre, Dokki, Egypt, 12622. Ricos Biology Journal aims to foster interdisciplinary communication by disseminating significant findings of broad interest and through accessible editorial content.

Article Types
Ricos Biology Journal welcomes submissions in various formats, including:

  • Research Articles
  • Review Articles
  • Case Reports
  • Case Studies
  • Educational Notes

ISSN: 2959-3751 (Electronic) / 2959-3743 (Print)

Ethical Conduct of Research
Studies Involving Human or Animal Subjects
Research involving human participants, human data, or animal subjects must have been conducted in accordance with internationally recognized guidelines.

  • Human Subjects: For manuscripts reporting on studies with human subjects, authors must declare that the study was approved by an appropriate institutional ethics committee and that it was conducted in accordance with the World Medical Association's Declaration of Helsinki. Authors must confirm that informed consent was obtained from all participants.

  • Animal Subjects: For studies involving experimental animals, authors must state that the work was approved by an institutional animal care and use committee and that all procedures were performed in accordance with relevant guidelines and regulations (e.g., the NIH Guide for the Care and Use of Laboratory Animals).

  • Manuscripts must include a statement within the "Methods" section confirming ethical approval and adherence to these standards.

Funding and Independence
Ricos Biology Journal is committed to transparent and unbiased scientific communication. To uphold this commitment, our operations are supported exclusively by article processing charges (APCs) paid by the authors. We consciously forgo sponsorships, institutional subsidies, and paid advertising. This singular revenue model ensures that our editorial decisions are made solely based on academic merit and rigor, free from any external commercial or organizational influence. It is the cornerstone of our mission to advance medical and life sciences research with integrity and an unwavering focus on quality.